Form EFFECT Agomab Therapeutics NV
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:01 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qivurn Data Centers Inc. Secures Dual U.S. Financial Regulatory Licenses, Laying a Solid Foundation for Global Strategic Financing Compliance
- Tron Price Prediction as TRX Holds Steady While Pepeto Presale Positions for Listing
- Crypto Market News Turns Defensive as Pepeto Presale Reaches $10.3 Million Milestone
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
